Advertisement
Home Tags Drug Approvals

Tag: Drug Approvals

The VenaSeal closure system has been approved by the U.S. Food and Drug Administration to treat superficial varicose veins of the legs that cause symptoms.

FDA: New Device Treats Superficial Varicose Veins

0
Seals the affected superficial veins using an adhesive agent
The U.S. Food and Drug Administration has allowed marketing of the Eclipse System for the treatment of fecal incontinence in adult women aged 18 to 75

FDA Permits Marketing of Device for Female Fecal Incontinence

0
Use of Eclipse System led to 50 percent decrease in episodes
The kinase inhibitor Lenvima (lenvatinib) has been approved by the U.S. Food and Drug Administration to treat differentiated thyroid cancer that has progressed despite radioactive iodine therapy

FDA Approves Lenvima for Type of Thyroid Cancer

0
To treat differentiated thyroid cancer that has progressed despite radioactive iodine therapy
The ENROUTE Transcarotid Neuroprotection System has been approved by the U.S. Food and Drug Administration as a minimally invasive device designed to help prevent stroke during stent and angioplasty procedures.

FDA OKs Device to Help Prevent Procedure-Related Stroke

0
Transcarotid system designed to help prevent stroke during stent and angioplasty procedures
The U.S. Food and Drug Administration has expanded the approved use for Lucentis (ranibizumab injection) 0.3 mg to treat diabetic retinopathy in patients with diabetic macular edema.

FDA Expands Approval of Lucentis for Diabetic Retinopathy

0
To treat diabetic retinopathy in patients with diabetic macular edema
Ibrance (palbociclib) has been approved by the U.S. Food and Drug Administration to treat advanced breast cancer among postmenopausal women.

FDA Approves Ibrance to Treat Advanced Breast Cancer

0
For postmenopausal women with ER+, HER2− metastatic breast cancer
The U.S. Food and Drug Administration has approved the first tissue adhesive for internal use.

FDA Approves Internal Tissue Adhesive

0
TissuGlu connects tissue flaps stemming from surgery to remove excess fat, skin from stomach
Vyvanse (lisdexamfetamine dimesylate) has been approved by the U.S. Food and Drug Administration to treat adults with binge-eating disorder.

FDA: Vyvanse Approved for Binge-Eating Disorder

0
Patients taking Vyvanse experienced a decrease in the number of binge eating days per week
The first generic version of Nexium (esomeprazole magnesium delayed-release capsules) has been approved by the U.S. Food and Drug Administration to treat gastroesophageal reflux disease in adults and children ages 1 and older.

FDA Approves Generic Form of Nexium

0
To treat gastroesophageal reflux disease in adults and children ages 1 and older
The Bexsero vaccine has been approved by the U.S. Food and Drug Administration to prevent serogroup B meningococcal disease among people aged 10 through 25.

FDA Approves New Meningococcal Disease Vaccine

0
Bexsero is the second vaccine approved in the past three months to prevent this disease